FUS and amyotrophic lateral sclerosis: However, in patients with ALS and FTD, FUS translocates into the cytoplasm, creating FUS inclusions that can boost further nefarious effects, such as RNA mislocation associated with sequestering of the motor protein kinesin-1 [77] and axonal transport impairments [78].